Donate
News + Publications
Careers
Donate
Contact
Back
Who
We Are
Board of Directors + Governance
Our Leadership
Our Team
Our Partners
Our Benefactors
Our History
Our Financials
Health Impact Reports
Our
Programs
All Programs
Accelerating Medicines Partnership® (AMP®)
Accelerating COVID-19 Therapeutic Interventions & Vaccines (ACTIV)
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Biomarkers Consortium
GeneConvene Global Collaborative
Azithromycin Prevention in Labor Use Study (A-PLUS)
Master Protocol for Treatment of Non-Small Cell Lung Cancer (Lung-MAP)
Partnership For Accelerating Cancer Therapies (PACT)
Edmond J. Safra Family Lodge
Global Pandemic Treaty
All of Us Scholars Program
Education & Training Programs
Fighting
Diseases
All Disease
Cancer
Cardiovascular
Infectious Diseases
Inflammation + Immunology
Maternal, Child + Newborn Health
Metabolic Disorders
Neuroscience
Rare Diseases
Powering
Science
Team Science Day 2024
FNIH Awards Ceremony
The Lurie Prize in Biomedical Sciences
Trailblazer Prize for Clinician-Scientists
Charles A. Sanders, MD Partnership Award
The Kovler Prize for Trust in Life Science Journalism
The Deeda Blair Research Initiative for Disorders of the Brain
Research Support
Fellowships & Training
Lectures
Patient
Voices
Patient and Family Resources
Donate
Partner With Us
FNIH 2023 HEALTH IMPACT REPORT
PEOPLE, FACTS, & FIGURES
Previous Annual Reports & Financial Information
2022
Health Impact Report
Audited Financials
Form 990
2021
Health Impact Report
Audited Financial Statements
Form 990
2020
Health Impact Report
Audited Financial Statements
Form 990
2019
Health Impact Report
Audited Financial Statements
Form 990
2018
Health Impact Report
Audited Financial Statements
Form 990
2017
Health Impact Report
Audited Financial Statements
Form 990
2016
Health Impact Report
Audited Financial Statements
Form 990
2015
Health Impact Report
Audited Financial Statements
Form 990
2014
Health Impact Report
Audited Financial Statements
Form 990
2023 Health Impact Report Home
Message from Leadership
Julie Gerberding, President and CEO
Accelerating New Therapies
Sickle Cell Disease
Bespoke Gene Therapy Consortium
NIMBLE
Pediatric Devices
Alzheimer’s Disease
Advancing Global Health
A-PLUS Trial
Pandemic Preparedness
GeneConvene
Powering Science
Lurie Prize
Trailblazer Prize
Partnership Award
Fellowships, Lectures & Training Programs
Patient Engagement
Patients First
Patient Voices
People, Facts & Figures
2023 Benefactors
2023 Board of Directors
Facts & Figures
Financials
Previous Health Impact Reports